GO:0002674 | negative regulation of acute inflammatory response | 4.88% (4/82) | 8.57 | 0.0 | 0.0 |
GO:1903699 | tarsal gland development | 4.88% (4/82) | 8.57 | 0.0 | 0.0 |
GO:1903709 | uterine gland development | 4.88% (4/82) | 8.57 | 0.0 | 0.0 |
GO:0002673 | regulation of acute inflammatory response | 4.88% (4/82) | 8.31 | 0.0 | 0.0 |
GO:0048733 | sebaceous gland development | 4.88% (4/82) | 8.31 | 0.0 | 0.0 |
GO:0046697 | decidualization | 4.88% (4/82) | 7.9 | 0.0 | 0.0 |
GO:0061038 | uterus morphogenesis | 4.88% (4/82) | 7.73 | 0.0 | 0.0 |
GO:0043409 | negative regulation of MAPK cascade | 8.54% (7/82) | 4.96 | 0.0 | 1e-06 |
GO:0048705 | skeletal system morphogenesis | 6.1% (5/82) | 6.46 | 0.0 | 1e-06 |
GO:0035441 | cell migration involved in vasculogenesis | 4.88% (4/82) | 7.31 | 0.0 | 1e-06 |
GO:0048332 | mesoderm morphogenesis | 4.88% (4/82) | 7.31 | 0.0 | 1e-06 |
GO:0060039 | pericardium development | 4.88% (4/82) | 7.31 | 0.0 | 1e-06 |
GO:0060669 | embryonic placenta morphogenesis | 4.88% (4/82) | 7.31 | 0.0 | 1e-06 |
GO:0097676 | histone H3-K36 dimethylation | 4.88% (4/82) | 7.31 | 0.0 | 1e-06 |
GO:0042799 | histone methyltransferase activity (H4-K20 specific) | 4.88% (4/82) | 7.2 | 0.0 | 1e-06 |
GO:0046965 | nuclear retinoid X receptor binding | 4.88% (4/82) | 7.2 | 0.0 | 1e-06 |
GO:0003149 | membranous septum morphogenesis | 4.88% (4/82) | 7.09 | 0.0 | 1e-06 |
GO:0003289 | atrial septum primum morphogenesis | 4.88% (4/82) | 7.09 | 0.0 | 1e-06 |
GO:0003290 | atrial septum secundum morphogenesis | 4.88% (4/82) | 7.09 | 0.0 | 1e-06 |
GO:0010793 | regulation of mRNA export from nucleus | 4.88% (4/82) | 6.99 | 0.0 | 2e-06 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 4.88% (4/82) | 6.99 | 0.0 | 2e-06 |
GO:0060977 | coronary vasculature morphogenesis | 4.88% (4/82) | 6.99 | 0.0 | 2e-06 |
GO:0003714 | transcription corepressor activity | 8.54% (7/82) | 4.47 | 0.0 | 2e-06 |
GO:0032647 | regulation of interferon-alpha production | 4.88% (4/82) | 6.81 | 0.0 | 3e-06 |
GO:0032727 | positive regulation of interferon-alpha production | 4.88% (4/82) | 6.81 | 0.0 | 3e-06 |
GO:0034770 | histone H4-K20 methylation | 4.88% (4/82) | 6.81 | 0.0 | 3e-06 |
GO:0001702 | gastrulation with mouth forming second | 4.88% (4/82) | 6.73 | 0.0 | 3e-06 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 4.88% (4/82) | 6.73 | 0.0 | 3e-06 |
GO:0048296 | regulation of isotype switching to IgA isotypes | 4.88% (4/82) | 6.73 | 0.0 | 3e-06 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 4.88% (4/82) | 6.73 | 0.0 | 3e-06 |
GO:0042974 | nuclear retinoic acid receptor binding | 4.88% (4/82) | 6.65 | 0.0 | 3e-06 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 4.88% (4/82) | 6.65 | 0.0 | 3e-06 |
GO:0048704 | embryonic skeletal system morphogenesis | 4.88% (4/82) | 6.65 | 0.0 | 3e-06 |
GO:0046975 | histone methyltransferase activity (H3-K36 specific) | 4.88% (4/82) | 6.57 | 0.0 | 4e-06 |
GO:0060413 | atrial septum morphogenesis | 4.88% (4/82) | 6.57 | 0.0 | 4e-06 |
GO:0018026 | peptidyl-lysine monomethylation | 4.88% (4/82) | 6.5 | 0.0 | 4e-06 |
GO:0046966 | nuclear thyroid hormone receptor binding | 4.88% (4/82) | 6.5 | 0.0 | 4e-06 |
GO:2000197 | regulation of ribonucleoprotein complex localization | 4.88% (4/82) | 6.5 | 0.0 | 4e-06 |
GO:0034340 | response to type I interferon | 4.88% (4/82) | 6.44 | 0.0 | 5e-06 |
GO:0031058 | positive regulation of histone modification | 8.54% (7/82) | 4.14 | 0.0 | 5e-06 |
GO:0035987 | endodermal cell differentiation | 4.88% (4/82) | 6.37 | 0.0 | 5e-06 |
GO:0045191 | regulation of isotype switching | 4.88% (4/82) | 6.37 | 0.0 | 5e-06 |
GO:0045830 | positive regulation of isotype switching | 4.88% (4/82) | 6.37 | 0.0 | 5e-06 |
GO:0050728 | negative regulation of inflammatory response | 4.88% (4/82) | 6.37 | 0.0 | 5e-06 |
GO:0060411 | cardiac septum morphogenesis | 4.88% (4/82) | 6.37 | 0.0 | 5e-06 |
GO:0002712 | regulation of B cell mediated immunity | 4.88% (4/82) | 6.31 | 0.0 | 6e-06 |
GO:0002714 | positive regulation of B cell mediated immunity | 4.88% (4/82) | 6.31 | 0.0 | 6e-06 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 4.88% (4/82) | 6.31 | 0.0 | 6e-06 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 4.88% (4/82) | 6.31 | 0.0 | 6e-06 |
GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 4.88% (4/82) | 6.31 | 0.0 | 6e-06 |
GO:0010452 | histone H3-K36 methylation | 4.88% (4/82) | 6.25 | 0.0 | 7e-06 |
GO:0046831 | regulation of RNA export from nucleus | 4.88% (4/82) | 6.2 | 0.0 | 8e-06 |
GO:0034401 | obsolete chromatin organization involved in regulation of transcription | 3.66% (3/82) | 7.67 | 0.0 | 9e-06 |
GO:0032239 | regulation of nucleobase-containing compound transport | 4.88% (4/82) | 6.14 | 0.0 | 9e-06 |
GO:0030317 | flagellated sperm motility | 4.88% (4/82) | 6.09 | 0.0 | 9e-06 |
GO:0060285 | cilium-dependent cell motility | 4.88% (4/82) | 6.09 | 0.0 | 9e-06 |
GO:0060294 | cilium movement involved in cell motility | 4.88% (4/82) | 6.09 | 0.0 | 9e-06 |
GO:0097722 | sperm motility | 4.88% (4/82) | 6.09 | 0.0 | 9e-06 |
GO:2001032 | regulation of double-strand break repair via nonhomologous end joining | 4.88% (4/82) | 6.09 | 0.0 | 9e-06 |
GO:0001539 | cilium or flagellum-dependent cell motility | 4.88% (4/82) | 5.99 | 0.0 | 1.2e-05 |
GO:0030331 | nuclear estrogen receptor binding | 4.88% (4/82) | 5.94 | 1e-06 | 1.4e-05 |
GO:0048514 | blood vessel morphogenesis | 4.88% (4/82) | 5.94 | 1e-06 | 1.4e-05 |
GO:0031056 | regulation of histone modification | 9.76% (8/82) | 3.5 | 1e-06 | 1.4e-05 |
GO:0007338 | single fertilization | 4.88% (4/82) | 5.9 | 1e-06 | 1.5e-05 |
GO:0018027 | peptidyl-lysine dimethylation | 4.88% (4/82) | 5.9 | 1e-06 | 1.5e-05 |
GO:0050871 | positive regulation of B cell activation | 4.88% (4/82) | 5.85 | 1e-06 | 1.7e-05 |
GO:0090548 | response to nitrate starvation | 4.88% (4/82) | 5.81 | 1e-06 | 1.8e-05 |
GO:0000414 | regulation of histone H3-K36 methylation | 4.88% (4/82) | 5.77 | 1e-06 | 2e-05 |
GO:0002639 | positive regulation of immunoglobulin production | 4.88% (4/82) | 5.77 | 1e-06 | 2e-05 |
GO:0006368 | transcription elongation by RNA polymerase II promoter | 4.88% (4/82) | 5.77 | 1e-06 | 2e-05 |
GO:0002637 | regulation of immunoglobulin production | 4.88% (4/82) | 5.73 | 1e-06 | 2.2e-05 |
GO:0042800 | histone methyltransferase activity (H3-K4 specific) | 4.88% (4/82) | 5.73 | 1e-06 | 2.2e-05 |
GO:0001843 | neural tube closure | 4.88% (4/82) | 5.69 | 1e-06 | 2.3e-05 |
GO:0030900 | forebrain development | 4.88% (4/82) | 5.69 | 1e-06 | 2.3e-05 |
GO:0060348 | bone development | 4.88% (4/82) | 5.69 | 1e-06 | 2.3e-05 |
GO:0060606 | tube closure | 4.88% (4/82) | 5.69 | 1e-06 | 2.3e-05 |
GO:0031063 | regulation of histone deacetylation | 4.88% (4/82) | 5.69 | 1e-06 | 2.3e-05 |
GO:0043014 | alpha-tubulin binding | 4.88% (4/82) | 5.65 | 1e-06 | 2.4e-05 |
GO:0050864 | regulation of B cell activation | 4.88% (4/82) | 5.65 | 1e-06 | 2.4e-05 |
GO:1905634 | regulation of protein localization to chromatin | 4.88% (4/82) | 5.65 | 1e-06 | 2.4e-05 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 4.88% (4/82) | 5.65 | 1e-06 | 2.4e-05 |
GO:0002821 | positive regulation of adaptive immune response | 4.88% (4/82) | 5.57 | 2e-06 | 2.9e-05 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.88% (4/82) | 5.57 | 2e-06 | 2.9e-05 |
GO:2000779 | regulation of double-strand break repair | 6.1% (5/82) | 4.7 | 2e-06 | 2.9e-05 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 4.88% (4/82) | 5.54 | 2e-06 | 3.1e-05 |
GO:0032481 | positive regulation of type I interferon production | 4.88% (4/82) | 5.54 | 2e-06 | 3.1e-05 |
GO:0003341 | cilium movement | 4.88% (4/82) | 5.5 | 2e-06 | 3.4e-05 |
GO:0048562 | embryonic organ morphogenesis | 4.88% (4/82) | 5.47 | 2e-06 | 3.7e-05 |
GO:0002706 | regulation of lymphocyte mediated immunity | 4.88% (4/82) | 5.44 | 2e-06 | 3.9e-05 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.88% (4/82) | 5.44 | 2e-06 | 3.9e-05 |
GO:0043408 | regulation of MAPK cascade | 8.54% (7/82) | 3.56 | 2e-06 | 4e-05 |
GO:0002819 | regulation of adaptive immune response | 4.88% (4/82) | 5.41 | 3e-06 | 4.2e-05 |
GO:0048864 | stem cell development | 4.88% (4/82) | 5.41 | 3e-06 | 4.2e-05 |
GO:0035148 | tube formation | 4.88% (4/82) | 5.34 | 3e-06 | 5e-05 |
GO:0050681 | nuclear androgen receptor binding | 4.88% (4/82) | 5.31 | 3e-06 | 5.3e-05 |
GO:0006298 | mismatch repair | 4.88% (4/82) | 5.28 | 4e-06 | 5.6e-05 |
GO:0006354 | DNA-templated transcription elongation | 4.88% (4/82) | 5.28 | 4e-06 | 5.6e-05 |
GO:0032465 | regulation of cytokinesis | 6.1% (5/82) | 4.45 | 4e-06 | 5.7e-05 |
GO:0002699 | positive regulation of immune effector process | 6.1% (5/82) | 4.39 | 4e-06 | 6.9e-05 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 9.76% (8/82) | 3.11 | 4e-06 | 6.9e-05 |
GO:0032479 | regulation of type I interferon production | 4.88% (4/82) | 5.14 | 5e-06 | 8.1e-05 |
GO:0002705 | positive regulation of leukocyte mediated immunity | 4.88% (4/82) | 5.12 | 6e-06 | 8.6e-05 |
GO:0046976 | histone methyltransferase activity (H3-K27 specific) | 3.66% (3/82) | 6.39 | 6e-06 | 8.9e-05 |
GO:0140537 | transcription regulator activator activity | 3.66% (3/82) | 6.39 | 6e-06 | 8.9e-05 |
GO:0090311 | regulation of protein deacetylation | 4.88% (4/82) | 5.09 | 6e-06 | 9e-05 |
GO:0051568 | histone H3-K4 methylation | 4.88% (4/82) | 5.06 | 7e-06 | 9.6e-05 |
GO:0003712 | transcription coregulator activity | 9.76% (8/82) | 3.02 | 7e-06 | 9.6e-05 |
GO:0002021 | response to dietary excess | 3.66% (3/82) | 6.31 | 7e-06 | 9.9e-05 |
GO:0045572 | positive regulation of imaginal disc growth | 3.66% (3/82) | 6.31 | 7e-06 | 9.9e-05 |
GO:0050872 | white fat cell differentiation | 3.66% (3/82) | 6.31 | 7e-06 | 9.9e-05 |
GO:0060613 | fat pad development | 3.66% (3/82) | 6.31 | 7e-06 | 9.9e-05 |
GO:0002697 | regulation of immune effector process | 6.1% (5/82) | 4.24 | 7e-06 | 9.9e-05 |
GO:0045911 | positive regulation of DNA recombination | 4.88% (4/82) | 5.04 | 7e-06 | 0.000101 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 4.88% (4/82) | 5.01 | 7e-06 | 0.000102 |
GO:0045570 | regulation of imaginal disc growth | 3.66% (3/82) | 6.23 | 8e-06 | 0.000114 |
GO:0007369 | gastrulation | 4.88% (4/82) | 4.97 | 9e-06 | 0.000115 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 4.88% (4/82) | 4.94 | 9e-06 | 0.000122 |
GO:0002703 | regulation of leukocyte mediated immunity | 4.88% (4/82) | 4.87 | 1.1e-05 | 0.000146 |
GO:0140297 | DNA-binding transcription factor binding | 8.54% (7/82) | 3.18 | 1.3e-05 | 0.000171 |
GO:0008587 | imaginal disc-derived wing margin morphogenesis | 3.66% (3/82) | 6.02 | 1.3e-05 | 0.000173 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 4.88% (4/82) | 4.79 | 1.4e-05 | 0.000179 |
GO:0140677 | molecular function activator activity | 4.88% (4/82) | 4.79 | 1.4e-05 | 0.000179 |
GO:0016108 | tetraterpenoid metabolic process | 4.88% (4/82) | 4.77 | 1.5e-05 | 0.000186 |
GO:0016116 | carotenoid metabolic process | 4.88% (4/82) | 4.77 | 1.5e-05 | 0.000186 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 3.66% (3/82) | 5.96 | 1.5e-05 | 0.000189 |
GO:2001255 | positive regulation of histone H3-K36 trimethylation | 3.66% (3/82) | 5.96 | 1.5e-05 | 0.000189 |
GO:0001525 | angiogenesis | 4.88% (4/82) | 4.75 | 1.6e-05 | 0.000192 |
GO:0031065 | positive regulation of histone deacetylation | 3.66% (3/82) | 5.9 | 1.7e-05 | 0.000212 |
GO:0000018 | regulation of DNA recombination | 6.1% (5/82) | 3.95 | 1.9e-05 | 0.000229 |
GO:0090312 | positive regulation of protein deacetylation | 3.66% (3/82) | 5.84 | 2e-05 | 0.000237 |
GO:0050727 | regulation of inflammatory response | 4.88% (4/82) | 4.65 | 2.1e-05 | 0.000244 |
GO:0006282 | regulation of DNA repair | 6.1% (5/82) | 3.91 | 2.2e-05 | 0.000261 |
GO:0002700 | regulation of production of molecular mediator of immune response | 4.88% (4/82) | 4.61 | 2.3e-05 | 0.000267 |
GO:0032386 | regulation of intracellular transport | 7.32% (6/82) | 3.39 | 2.4e-05 | 0.00028 |
GO:0051251 | positive regulation of lymphocyte activation | 4.88% (4/82) | 4.57 | 2.5e-05 | 0.00029 |
GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 6.1% (5/82) | 3.86 | 2.6e-05 | 0.000294 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 4.88% (4/82) | 4.52 | 2.9e-05 | 0.000331 |
GO:2001253 | regulation of histone H3-K36 trimethylation | 3.66% (3/82) | 5.62 | 3.1e-05 | 0.000352 |
GO:1902532 | negative regulation of intracellular signal transduction | 8.54% (7/82) | 2.96 | 3.4e-05 | 0.000377 |
GO:0002696 | positive regulation of leukocyte activation | 4.88% (4/82) | 4.45 | 3.5e-05 | 0.00039 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 9.76% (8/82) | 2.66 | 4e-05 | 0.000439 |
GO:0007017 | microtubule-based process | 10.98% (9/82) | 2.45 | 4e-05 | 0.000439 |
GO:0010363 | regulation of plant-type hypersensitive response | 4.88% (4/82) | 4.39 | 4.2e-05 | 0.000455 |
GO:0071441 | negative regulation of histone H3-K14 acetylation | 2.44% (2/82) | 7.57 | 4.3e-05 | 0.000468 |
GO:0070050 | neuron cellular homeostasis | 3.66% (3/82) | 5.44 | 4.6e-05 | 0.000497 |
GO:0050867 | positive regulation of cell activation | 4.88% (4/82) | 4.34 | 4.8e-05 | 0.000506 |
GO:0051249 | regulation of lymphocyte activation | 4.88% (4/82) | 4.33 | 5e-05 | 0.000524 |
GO:0018024 | histone-lysine N-methyltransferase activity | 4.88% (4/82) | 4.3 | 5.4e-05 | 0.000564 |
GO:0060612 | adipose tissue development | 3.66% (3/82) | 5.35 | 5.5e-05 | 0.000579 |
GO:0022416 | chaeta development | 3.66% (3/82) | 5.31 | 6e-05 | 0.000622 |
GO:0061448 | connective tissue development | 3.66% (3/82) | 5.31 | 6e-05 | 0.000622 |
GO:0045747 | positive regulation of Notch signaling pathway | 3.66% (3/82) | 5.27 | 6.6e-05 | 0.000659 |
GO:0090207 | regulation of triglyceride metabolic process | 3.66% (3/82) | 5.27 | 6.6e-05 | 0.000659 |
GO:0010223 | secondary shoot formation | 4.88% (4/82) | 4.22 | 6.5e-05 | 0.000664 |
GO:0010346 | shoot axis formation | 4.88% (4/82) | 4.22 | 6.5e-05 | 0.000664 |
GO:0003682 | chromatin binding | 9.76% (8/82) | 2.54 | 7.1e-05 | 0.000707 |
GO:0042461 | photoreceptor cell development | 3.66% (3/82) | 5.23 | 7.1e-05 | 0.00071 |
GO:0016278 | lysine N-methyltransferase activity | 4.88% (4/82) | 4.13 | 8.5e-05 | 0.000817 |
GO:0016279 | protein-lysine N-methyltransferase activity | 4.88% (4/82) | 4.13 | 8.5e-05 | 0.000817 |
GO:0016922 | nuclear receptor binding | 4.88% (4/82) | 4.13 | 8.5e-05 | 0.000817 |
GO:0046329 | negative regulation of JNK cascade | 3.66% (3/82) | 5.16 | 8.3e-05 | 0.000818 |
GO:0051101 | regulation of DNA binding | 4.88% (4/82) | 4.1 | 9.1e-05 | 0.000866 |
GO:0070201 | regulation of establishment of protein localization | 7.32% (6/82) | 3.05 | 9.2e-05 | 0.000869 |
GO:0071440 | regulation of histone H3-K14 acetylation | 2.44% (2/82) | 7.09 | 9.1e-05 | 0.00087 |
GO:0042054 | histone methyltransferase activity | 4.88% (4/82) | 4.03 | 0.000111 | 0.001043 |
GO:0045444 | fat cell differentiation | 3.66% (3/82) | 5.02 | 0.000111 | 0.001044 |
GO:0048639 | positive regulation of developmental growth | 6.1% (5/82) | 3.41 | 0.000113 | 0.001049 |
GO:0001819 | positive regulation of cytokine production | 4.88% (4/82) | 4.01 | 0.000115 | 0.001065 |
GO:0002694 | regulation of leukocyte activation | 4.88% (4/82) | 4.0 | 0.000119 | 0.001094 |
GO:0043903 | regulation of biological process involved in symbiotic interaction | 4.88% (4/82) | 3.95 | 0.000135 | 0.0012 |
GO:0060429 | epithelium development | 4.88% (4/82) | 3.95 | 0.000135 | 0.0012 |
GO:0000987 | cis-regulatory region sequence-specific DNA binding | 8.54% (7/82) | 2.65 | 0.000133 | 0.001213 |
GO:0001835 | blastocyst hatching | 3.66% (3/82) | 4.93 | 0.000135 | 0.001213 |
GO:0035188 | hatching | 3.66% (3/82) | 4.93 | 0.000135 | 0.001213 |
GO:0071684 | organism emergence from protective structure | 3.66% (3/82) | 4.93 | 0.000135 | 0.001213 |
GO:0043627 | response to estrogen | 3.66% (3/82) | 4.9 | 0.000144 | 0.00127 |
GO:0008013 | beta-catenin binding | 3.66% (3/82) | 4.87 | 0.000153 | 0.001343 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 2.44% (2/82) | 6.73 | 0.000155 | 0.001347 |
GO:1900049 | regulation of histone exchange | 2.44% (2/82) | 6.73 | 0.000155 | 0.001347 |
GO:0050865 | regulation of cell activation | 4.88% (4/82) | 3.9 | 0.000157 | 0.00136 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 3.66% (3/82) | 4.84 | 0.000162 | 0.001388 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 3.66% (3/82) | 4.84 | 0.000162 | 0.001388 |
GO:0007018 | microtubule-based movement | 6.1% (5/82) | 3.29 | 0.000165 | 0.001399 |
GO:0008134 | transcription factor binding | 8.54% (7/82) | 2.58 | 0.000176 | 0.001484 |
GO:0046822 | regulation of nucleocytoplasmic transport | 4.88% (4/82) | 3.85 | 0.000177 | 0.00149 |
GO:0080135 | regulation of cellular response to stress | 9.76% (8/82) | 2.35 | 0.000181 | 0.001512 |
GO:0007605 | sensory perception of sound | 3.66% (3/82) | 4.75 | 0.000193 | 0.001598 |
GO:0050954 | sensory perception of mechanical stimulus | 3.66% (3/82) | 4.75 | 0.000193 | 0.001598 |
GO:0031062 | positive regulation of histone methylation | 4.88% (4/82) | 3.81 | 0.000199 | 0.001626 |
GO:0035239 | tube morphogenesis | 4.88% (4/82) | 3.81 | 0.000199 | 0.001626 |
GO:0008276 | protein methyltransferase activity | 4.88% (4/82) | 3.8 | 0.000204 | 0.001664 |
GO:2001020 | regulation of response to DNA damage stimulus | 6.1% (5/82) | 3.22 | 0.000206 | 0.001667 |
GO:0001763 | morphogenesis of a branching structure | 4.88% (4/82) | 3.78 | 0.000216 | 0.00174 |
GO:0060194 | regulation of antisense RNA transcription | 2.44% (2/82) | 6.44 | 0.000236 | 0.001864 |
GO:0060195 | negative regulation of antisense RNA transcription | 2.44% (2/82) | 6.44 | 0.000236 | 0.001864 |
GO:0009910 | negative regulation of flower development | 4.88% (4/82) | 3.75 | 0.000234 | 0.001869 |
GO:0031401 | positive regulation of protein modification process | 8.54% (7/82) | 2.51 | 0.000234 | 0.001876 |
GO:0009566 | fertilization | 4.88% (4/82) | 3.74 | 0.000241 | 0.001891 |
GO:0008170 | N-methyltransferase activity | 4.88% (4/82) | 3.73 | 0.000247 | 0.001922 |
GO:0048481 | plant ovule development | 4.88% (4/82) | 3.73 | 0.000247 | 0.001922 |
GO:0031348 | negative regulation of defense response | 8.54% (7/82) | 2.49 | 0.000251 | 0.001945 |
GO:0009887 | animal organ morphogenesis | 6.1% (5/82) | 3.16 | 0.000255 | 0.001959 |
GO:0008593 | regulation of Notch signaling pathway | 3.66% (3/82) | 4.6 | 0.000266 | 0.002036 |
GO:2000616 | negative regulation of histone H3-K9 acetylation | 2.44% (2/82) | 6.31 | 0.000283 | 0.002157 |
GO:0046328 | regulation of JNK cascade | 3.66% (3/82) | 4.46 | 0.000354 | 0.002684 |
GO:0043524 | negative regulation of neuron apoptotic process | 3.66% (3/82) | 4.42 | 0.000387 | 0.002907 |
GO:0034968 | histone lysine methylation | 4.88% (4/82) | 3.56 | 0.000387 | 0.002919 |
GO:0018205 | peptidyl-lysine modification | 7.32% (6/82) | 2.65 | 0.0004 | 0.002987 |
GO:0045910 | negative regulation of DNA recombination | 3.66% (3/82) | 4.39 | 0.000404 | 0.003007 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 3.66% (3/82) | 4.37 | 0.000422 | 0.003124 |
GO:0017053 | transcription repressor complex | 3.66% (3/82) | 4.31 | 0.000478 | 0.003523 |
GO:0051098 | regulation of binding | 6.1% (5/82) | 2.95 | 0.000489 | 0.003585 |
GO:0045835 | negative regulation of meiotic nuclear division | 2.44% (2/82) | 5.9 | 0.000512 | 0.003736 |
GO:1901184 | regulation of ERBB signaling pathway | 3.66% (3/82) | 4.25 | 0.000539 | 0.003915 |
GO:0018022 | peptidyl-lysine methylation | 4.88% (4/82) | 3.41 | 0.000563 | 0.004072 |
GO:0009553 | embryo sac development | 4.88% (4/82) | 3.37 | 0.000624 | 0.004494 |
GO:0001817 | regulation of cytokine production | 4.88% (4/82) | 3.37 | 0.000637 | 0.004565 |
GO:0051094 | positive regulation of developmental process | 12.2% (10/82) | 1.78 | 0.000656 | 0.004676 |
GO:0035264 | multicellular organism growth | 3.66% (3/82) | 4.14 | 0.000675 | 0.004791 |
GO:0030276 | clathrin binding | 3.66% (3/82) | 4.12 | 0.000699 | 0.00492 |
GO:0005700 | polytene chromosome | 3.66% (3/82) | 4.12 | 0.000699 | 0.00492 |
GO:0006357 | regulation of transcription by RNA polymerase II | 12.2% (10/82) | 1.76 | 0.000727 | 0.005073 |
GO:0047485 | protein N-terminus binding | 3.66% (3/82) | 4.11 | 0.000724 | 0.005074 |
GO:0016571 | histone methylation | 4.88% (4/82) | 3.29 | 0.000775 | 0.005358 |
GO:0048598 | embryonic morphogenesis | 6.1% (5/82) | 2.81 | 0.000773 | 0.005366 |
GO:2000615 | regulation of histone H3-K9 acetylation | 2.44% (2/82) | 5.57 | 0.000806 | 0.005545 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 3.66% (3/82) | 4.02 | 0.000859 | 0.005882 |
GO:0048729 | tissue morphogenesis | 4.88% (4/82) | 3.25 | 0.000868 | 0.005918 |
GO:0048732 | gland development | 4.88% (4/82) | 3.24 | 0.000884 | 0.006002 |
GO:0015631 | tubulin binding | 6.1% (5/82) | 2.74 | 0.000937 | 0.006332 |
GO:0009886 | post-embryonic animal morphogenesis | 3.66% (3/82) | 3.94 | 0.001008 | 0.006784 |
GO:0016570 | histone modification | 7.32% (6/82) | 2.39 | 0.001013 | 0.006789 |
GO:1905393 | plant organ formation | 7.32% (6/82) | 2.39 | 0.001022 | 0.006824 |
GO:0051052 | regulation of DNA metabolic process | 7.32% (6/82) | 2.38 | 0.001052 | 0.006988 |
GO:0000118 | histone deacetylase complex | 3.66% (3/82) | 3.9 | 0.001105 | 0.007309 |
GO:0032774 | RNA biosynthetic process | 6.1% (5/82) | 2.68 | 0.001125 | 0.007411 |
GO:0016477 | cell migration | 4.88% (4/82) | 3.11 | 0.001232 | 0.008083 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 15.85% (13/82) | 1.39 | 0.001252 | 0.008178 |
GO:0030177 | positive regulation of Wnt signaling pathway | 3.66% (3/82) | 3.82 | 0.001279 | 0.008285 |
GO:0051054 | positive regulation of DNA metabolic process | 4.88% (4/82) | 3.1 | 0.001273 | 0.008285 |
GO:0000226 | microtubule cytoskeleton organization | 7.32% (6/82) | 2.32 | 0.001297 | 0.008369 |
GO:0048468 | cell development | 8.54% (7/82) | 2.09 | 0.001305 | 0.008386 |
GO:1902531 | regulation of intracellular signal transduction | 9.76% (8/82) | 1.91 | 0.001324 | 0.008473 |
GO:0072686 | mitotic spindle | 3.66% (3/82) | 3.8 | 0.001353 | 0.008622 |
GO:0035066 | positive regulation of histone acetylation | 2.44% (2/82) | 5.2 | 0.001367 | 0.008679 |
GO:0045892 | negative regulation of DNA-templated transcription | 10.98% (9/82) | 1.75 | 0.001417 | 0.008956 |
GO:0007423 | sensory organ development | 3.66% (3/82) | 3.77 | 0.00143 | 0.009001 |
GO:0031060 | regulation of histone methylation | 4.88% (4/82) | 3.05 | 0.001449 | 0.009087 |
GO:0048666 | neuron development | 3.66% (3/82) | 3.75 | 0.001469 | 0.009175 |
GO:1902679 | negative regulation of RNA biosynthetic process | 10.98% (9/82) | 1.74 | 0.001495 | 0.009224 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 10.98% (9/82) | 1.74 | 0.001495 | 0.009224 |
GO:0000123 | histone acetyltransferase complex | 3.66% (3/82) | 3.74 | 0.001509 | 0.009277 |
GO:0032880 | regulation of protein localization | 7.32% (6/82) | 2.28 | 0.001492 | 0.009281 |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.1% (5/82) | 2.58 | 0.001532 | 0.009381 |
GO:0051447 | negative regulation of meiotic cell cycle | 2.44% (2/82) | 5.09 | 0.001586 | 0.009634 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 2.44% (2/82) | 5.09 | 0.001586 | 0.009634 |
GO:0051302 | regulation of cell division | 6.1% (5/82) | 2.56 | 0.001618 | 0.009792 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 12.2% (10/82) | 1.6 | 0.001648 | 0.009933 |
GO:0006479 | protein methylation | 4.88% (4/82) | 2.99 | 0.001666 | 0.009966 |
GO:0008213 | protein alkylation | 4.88% (4/82) | 2.99 | 0.001666 | 0.009966 |
GO:0030437 | ascospore formation | 2.44% (2/82) | 5.04 | 0.001701 | 0.010136 |
GO:1901215 | negative regulation of neuron death | 3.66% (3/82) | 3.67 | 0.00172 | 0.01021 |
GO:0032872 | regulation of stress-activated MAPK cascade | 3.66% (3/82) | 3.66 | 0.001764 | 0.010432 |
GO:0010520 | regulation of reciprocal meiotic recombination | 2.44% (2/82) | 4.99 | 0.00182 | 0.010562 |
GO:0022413 | reproductive process in single-celled organism | 2.44% (2/82) | 4.99 | 0.00182 | 0.010562 |
GO:0030174 | regulation of DNA-templated DNA replication initiation | 2.44% (2/82) | 4.99 | 0.00182 | 0.010562 |
GO:0140747 | regulation of ncRNA transcription | 2.44% (2/82) | 4.99 | 0.00182 | 0.010562 |
GO:1901985 | positive regulation of protein acetylation | 2.44% (2/82) | 4.99 | 0.00182 | 0.010562 |
GO:0098772 | molecular function regulator activity | 9.76% (8/82) | 1.83 | 0.001886 | 0.010904 |
GO:0048653 | anther development | 4.88% (4/82) | 2.93 | 0.001933 | 0.011134 |
GO:0007010 | cytoskeleton organization | 8.54% (7/82) | 1.99 | 0.001957 | 0.011231 |
GO:0042176 | regulation of protein catabolic process | 6.1% (5/82) | 2.49 | 0.001998 | 0.011424 |
GO:0005819 | spindle | 4.88% (4/82) | 2.91 | 0.002048 | 0.011621 |
GO:0043523 | regulation of neuron apoptotic process | 3.66% (3/82) | 3.59 | 0.002045 | 0.011648 |
GO:0031248 | protein acetyltransferase complex | 3.66% (3/82) | 3.57 | 0.002094 | 0.011757 |
GO:1902493 | acetyltransferase complex | 3.66% (3/82) | 3.57 | 0.002094 | 0.011757 |
GO:0045927 | positive regulation of growth | 6.1% (5/82) | 2.48 | 0.002082 | 0.01177 |
GO:0060249 | anatomical structure homeostasis | 3.66% (3/82) | 3.56 | 0.002144 | 0.011994 |
GO:0051726 | regulation of cell cycle | 9.76% (8/82) | 1.79 | 0.002175 | 0.012124 |
GO:0043067 | regulation of programmed cell death | 9.76% (8/82) | 1.79 | 0.002225 | 0.012355 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 3.66% (3/82) | 3.54 | 0.002247 | 0.012432 |
GO:0048513 | animal organ development | 9.76% (8/82) | 1.78 | 0.002262 | 0.012474 |
GO:0040029 | epigenetic regulation of gene expression | 4.88% (4/82) | 2.86 | 0.002291 | 0.012543 |
GO:0048870 | cell motility | 4.88% (4/82) | 2.86 | 0.002291 | 0.012543 |
GO:0031399 | regulation of protein modification process | 9.76% (8/82) | 1.78 | 0.002339 | 0.012761 |
GO:0000976 | transcription cis-regulatory region binding | 13.41% (11/82) | 1.44 | 0.002353 | 0.012792 |
GO:0042393 | histone binding | 4.88% (4/82) | 2.84 | 0.002419 | 0.013063 |
GO:0001067 | transcription regulatory region nucleic acid binding | 13.41% (11/82) | 1.43 | 0.002419 | 0.013108 |
GO:0035097 | histone methyltransferase complex | 3.66% (3/82) | 3.49 | 0.00246 | 0.013237 |
GO:0070461 | SAGA-type complex | 2.44% (2/82) | 4.77 | 0.002473 | 0.01326 |
GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 4.88% (4/82) | 2.83 | 0.002486 | 0.013282 |
GO:0043087 | regulation of GTPase activity | 3.66% (3/82) | 3.47 | 0.002571 | 0.013646 |
GO:0031057 | negative regulation of histone modification | 3.66% (3/82) | 3.47 | 0.002571 | 0.013646 |
GO:0043935 | sexual sporulation resulting in formation of a cellular spore | 2.44% (2/82) | 4.73 | 0.002615 | 0.01383 |
GO:0009888 | tissue development | 10.98% (9/82) | 1.62 | 0.00263 | 0.013863 |
GO:1990837 | sequence-specific double-stranded DNA binding | 13.41% (11/82) | 1.4 | 0.002809 | 0.014756 |
GO:0007600 | sensory perception | 3.66% (3/82) | 3.42 | 0.002863 | 0.01494 |
GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 3.66% (3/82) | 3.42 | 0.002863 | 0.01494 |
GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 6.1% (5/82) | 2.37 | 0.002894 | 0.015053 |
GO:0042273 | ribosomal large subunit biogenesis | 2.44% (2/82) | 4.61 | 0.003063 | 0.015877 |
GO:0051253 | negative regulation of RNA metabolic process | 10.98% (9/82) | 1.58 | 0.003085 | 0.015936 |
GO:0060341 | regulation of cellular localization | 7.32% (6/82) | 2.05 | 0.003357 | 0.01723 |
GO:0065009 | regulation of molecular function | 13.41% (11/82) | 1.37 | 0.003347 | 0.017233 |
GO:0060828 | regulation of canonical Wnt signaling pathway | 3.66% (3/82) | 3.31 | 0.003506 | 0.017932 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.66% (3/82) | 3.26 | 0.003857 | 0.019666 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 10.98% (9/82) | 1.53 | 0.004003 | 0.020341 |
GO:0051607 | defense response to virus | 4.88% (4/82) | 2.63 | 0.004083 | 0.020615 |
GO:0140546 | defense response to symbiont | 4.88% (4/82) | 2.63 | 0.004083 | 0.020615 |
GO:0020033 | antigenic variation | 1.22% (1/82) | 7.9 | 0.004191 | 0.020823 |
GO:1900245 | positive regulation of MDA-5 signaling pathway | 1.22% (1/82) | 7.9 | 0.004191 | 0.020823 |
GO:0051245 | negative regulation of cellular defense response | 1.22% (1/82) | 7.9 | 0.004191 | 0.020823 |
GO:0036158 | outer dynein arm assembly | 1.22% (1/82) | 7.9 | 0.004191 | 0.020823 |
GO:0048545 | response to steroid hormone | 3.66% (3/82) | 3.22 | 0.004154 | 0.020903 |
GO:0034708 | methyltransferase complex | 3.66% (3/82) | 3.22 | 0.00423 | 0.020947 |
GO:0008022 | protein C-terminus binding | 3.66% (3/82) | 3.2 | 0.004385 | 0.021646 |
GO:0051049 | regulation of transport | 10.98% (9/82) | 1.5 | 0.004478 | 0.021969 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 4.88% (4/82) | 2.59 | 0.00447 | 0.021996 |
GO:0051053 | negative regulation of DNA metabolic process | 3.66% (3/82) | 3.17 | 0.004624 | 0.022538 |
GO:0140110 | transcription regulator activity | 13.41% (11/82) | 1.31 | 0.004624 | 0.022609 |
GO:0010564 | regulation of cell cycle process | 7.32% (6/82) | 1.94 | 0.004863 | 0.023632 |
GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process | 3.66% (3/82) | 3.12 | 0.005039 | 0.024409 |
GO:0045893 | positive regulation of DNA-templated transcription | 12.2% (10/82) | 1.37 | 0.005178 | 0.02493 |
GO:0003690 | double-stranded DNA binding | 13.41% (11/82) | 1.29 | 0.005168 | 0.024957 |
GO:0098876 | vesicle-mediated transport to the plasma membrane | 3.66% (3/82) | 3.08 | 0.005476 | 0.02628 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 10.98% (9/82) | 1.45 | 0.005494 | 0.026289 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 12.2% (10/82) | 1.36 | 0.005517 | 0.026313 |
GO:1902680 | positive regulation of RNA biosynthetic process | 12.2% (10/82) | 1.36 | 0.005557 | 0.026427 |
GO:0016575 | histone deacetylation | 2.44% (2/82) | 4.17 | 0.005589 | 0.026497 |
GO:0006476 | protein deacetylation | 2.44% (2/82) | 4.12 | 0.006007 | 0.028391 |
GO:0010605 | negative regulation of macromolecule metabolic process | 15.85% (13/82) | 1.12 | 0.00613 | 0.028883 |
GO:0042783 | evasion of host immune response | 1.22% (1/82) | 7.31 | 0.00628 | 0.029153 |
GO:0097198 | histone H3-K36 trimethylation | 1.22% (1/82) | 7.31 | 0.00628 | 0.029153 |
GO:0039533 | regulation of MDA-5 signaling pathway | 1.22% (1/82) | 7.31 | 0.00628 | 0.029153 |
GO:0110030 | regulation of G2/MI transition of meiotic cell cycle | 1.22% (1/82) | 7.31 | 0.00628 | 0.029153 |
GO:0001826 | inner cell mass cell differentiation | 1.22% (1/82) | 7.31 | 0.00628 | 0.029153 |
GO:0032259 | methylation | 6.1% (5/82) | 2.1 | 0.006358 | 0.029249 |
GO:0034097 | response to cytokine | 4.88% (4/82) | 2.45 | 0.006326 | 0.029275 |
GO:0010941 | regulation of cell death | 9.76% (8/82) | 1.54 | 0.006352 | 0.02931 |
GO:0048585 | negative regulation of response to stimulus | 13.41% (11/82) | 1.24 | 0.006667 | 0.030579 |
GO:1901214 | regulation of neuron death | 3.66% (3/82) | 2.97 | 0.006716 | 0.030715 |
GO:0009555 | pollen development | 7.32% (6/82) | 1.84 | 0.006777 | 0.030904 |
GO:0051247 | positive regulation of protein metabolic process | 8.54% (7/82) | 1.65 | 0.006903 | 0.031296 |
GO:0051784 | negative regulation of nuclear division | 2.44% (2/82) | 4.01 | 0.006884 | 0.031298 |
GO:0035067 | negative regulation of histone acetylation | 2.44% (2/82) | 3.99 | 0.007111 | 0.032053 |
GO:0010224 | response to UV-B | 4.88% (4/82) | 2.4 | 0.007111 | 0.032143 |
GO:0050877 | nervous system process | 4.88% (4/82) | 2.39 | 0.007316 | 0.032882 |
GO:0006353 | DNA-templated transcription termination | 2.44% (2/82) | 3.94 | 0.007577 | 0.033954 |
GO:1990234 | transferase complex | 8.54% (7/82) | 1.62 | 0.007725 | 0.034517 |
GO:1901800 | positive regulation of proteasomal protein catabolic process | 3.66% (3/82) | 2.89 | 0.007886 | 0.035035 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 4.88% (4/82) | 2.36 | 0.007884 | 0.03513 |
GO:0043414 | macromolecule methylation | 4.88% (4/82) | 2.35 | 0.008105 | 0.035906 |
GO:0048581 | negative regulation of post-embryonic development | 6.1% (5/82) | 2.01 | 0.008275 | 0.03645 |
GO:0031327 | negative regulation of cellular biosynthetic process | 10.98% (9/82) | 1.36 | 0.008271 | 0.036538 |
GO:0070843 | misfolded protein transport | 1.22% (1/82) | 6.9 | 0.008365 | 0.036539 |
GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1.22% (1/82) | 6.9 | 0.008365 | 0.036539 |
GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1.22% (1/82) | 6.9 | 0.008365 | 0.036539 |
GO:0030111 | regulation of Wnt signaling pathway | 3.66% (3/82) | 2.85 | 0.008571 | 0.037126 |
GO:0040020 | regulation of meiotic nuclear division | 2.44% (2/82) | 3.85 | 0.008548 | 0.03713 |
GO:2000757 | negative regulation of peptidyl-lysine acetylation | 2.44% (2/82) | 3.85 | 0.008548 | 0.03713 |
GO:0035091 | phosphatidylinositol binding | 3.66% (3/82) | 2.82 | 0.008927 | 0.038558 |
GO:0035601 | protein deacylation | 2.44% (2/82) | 3.79 | 0.009312 | 0.040109 |
GO:2000242 | negative regulation of reproductive process | 4.88% (4/82) | 2.28 | 0.009512 | 0.040858 |
GO:0000775 | chromosome, centromeric region | 2.44% (2/82) | 3.77 | 0.009572 | 0.041006 |
GO:0009890 | negative regulation of biosynthetic process | 10.98% (9/82) | 1.33 | 0.009642 | 0.04119 |
GO:0051248 | negative regulation of protein metabolic process | 7.32% (6/82) | 1.72 | 0.009799 | 0.041745 |
GO:0043565 | sequence-specific DNA binding | 13.41% (11/82) | 1.16 | 0.009917 | 0.042132 |
GO:0098732 | macromolecule deacylation | 2.44% (2/82) | 3.73 | 0.010104 | 0.042811 |
GO:1900027 | regulation of ruffle assembly | 1.22% (1/82) | 6.57 | 0.010446 | 0.0439 |
GO:0019864 | IgG binding | 1.22% (1/82) | 6.57 | 0.010446 | 0.0439 |
GO:1903052 | positive regulation of proteolysis involved in protein catabolic process | 3.66% (3/82) | 2.74 | 0.010435 | 0.044092 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.66% (3/82) | 2.73 | 0.010699 | 0.044845 |
GO:1901984 | negative regulation of protein acetylation | 2.44% (2/82) | 3.67 | 0.010925 | 0.045669 |
GO:0051254 | positive regulation of RNA metabolic process | 12.2% (10/82) | 1.21 | 0.011014 | 0.045918 |
GO:0043547 | positive regulation of GTPase activity | 2.44% (2/82) | 3.65 | 0.011205 | 0.04659 |